Skip to content

ISOPP Quality and Equity in Cancer Treatment Supply Task Force (QETF) Survey

Background: Thank you for taking the time to complete this brief survey! This data will help us identify and characterize the barriers and facilitators associated with ensuring access to high-quality anticancer medications across different settings.

Important Definitions (according to the World Health Organization):
  • Substandard Anticancer Medications: authorized medications that fail to meet either their quality standards or specifications, or both
  • Falsified Anticancer Medications: medications that are deliberately/fraudulently misrepresented
Participant Information:
1.Name:(Required.)
2.Country of Practice:(Required.)
3.If we have further questions would it be okay for us to reach out to you? If so, please add your email address for further communication.
General Information:
4.What type of organization are you primarily affiliated with?(Required.)
5.What best describes the ownership type of your affiliated organization:(Required.)
6.Which of the following best describes your role?(Required.)
7.How familiar are you with your organization’s anticancer medication procurement, storage, preparation, and quality-assurance processes?(Required.)
8.Does your country have a regulatory agency responsible for overseeing medication quality and safety standards?(Required.)